MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Chemo Drugs May Cause Cognitive Dysfunction

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Chemo Drugs May Cause Cognitive Dysfunction

Chemo Drugs May Cause Cognitive Dysfunction
A new study investigating the effects of chemotherapy on cognitive function in mice has confirmed what a number of cancer patients receiving therapy have often complained about a decline in their memory and other cognitive functions, sometimes characterized as "chemobrain".

The study, led by Dr. Gordon Winocur of the Baycrest Research Centre for Aging and the Brain, in collaboration with Drs. Ian Tannock and Janette Vardy of Princess Margaret Hospital, was conducted at Trent University. The findings are published in the September 2006 issue of Pharmacology, Biochemistry and Behavior (Vol. 85, Issue 1), which will be available online in the next week. The results were presented at a workshop held in conjunction with the 8th World Congress of Psycho-Oncology in Venice last week.

"In our study, we identified learning and memory deficits in the mild to moderate range in the drug-treated mice in comparison to the controls," says Dr. Winocur.

"That the deficits were relatively small is encouraging. It's important that cancer patients continue with these drugs and know that if they experience mild to moderate impairments in their cognitive functions, this level of change is potentially manageable".

While there is growing evidence from studies of cancer patients on chemotherapy that the chemobrain effect does exist, a number of of the studies have suffered from methodological limitations. These include small samples, less than adequate controls and failure to account for other factors, including disease-related complications and stress, which could affect performance.

This latest study, using an animal model, afforded scientists the opportunity to look at the direct effects of chemotherapy drugs on cognitive performance without interference from potentially confounding variables.

In the study, 25 healthy female mice were split into two groups: the drug therapy group received standard doses of methotrexate and 5-fluorouracil (5FU), two drugs widely used in women to prevent recurrence of breast cancer; and the control group received a saline solution. Both groups were given their therapys over three weeks.

One week after the final injection they were put through a series of spatial/non-spatial memory tests and conditional rule learning tests in a water maze. The behavioral tasks enabled researchers to assess various aspects of learning and memory linked to different brain regions. The drug therapy group scored lower on the spatial memory task (hippocampus) and the task requiring strategic and working memory components (frontal lobes), particularly when there were long delay intervals, in comparison to the control group. The drug group was not impaired on a cued memory test or in discrimination learning, tasks that are not affected by selective damage to the frontal lobes or hippocampus.

"This indicates that the adverse effects of this therapy regimen of methotrexate and 5FU probably do not extend to all regions of the brain. It appears that the hippocampus and frontal lobes are primarily affected," says Dr. Winocur.

Because the behavioral testing was initiated two weeks after the last therapy and completed within four to five weeks, the study assessed only the short-term effects of the drugs. This is important because it raises the possibility that at longer therapy intervals there might have been some recovery of cognitive function, notes Dr. Winocur.


Posted by: Janet    Source




Did you know?
A new study investigating the effects of chemotherapy on cognitive function in mice has confirmed what a number of cancer patients receiving therapy have often complained about a decline in their memory and other cognitive functions, sometimes characterized as "chemobrain".

Medicineworld.org: Chemo Drugs May Cause Cognitive Dysfunction

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.